Expression of MUC1, MUC2, MUC5AC, and MUC6 in atypical adenomatous hyperplasia, bronchioloalveolar carcinoma, adenocarcinoma with mixed subtypes, and mucinous bronchioloalveolar carcinoma of the lung

被引:83
作者
Awaya, H
Takeshima, Y
Yamasaki, M
Inai, K
机构
[1] Hiroshima Univ, Grad Sch Biomed Sci, Dept Pathol, Minami Ku, Hiroshima 7348551, Japan
[2] Hiroshima Univ, Grad Sch Biomed Sci, Dept Mol & Internal Med, Hiroshima 7348551, Japan
[3] Mitsugi Publ Hosp, Dept Internal Med, Hiroshima, Japan
关键词
MUC; atypical adenomatous hyperplasia; bronchioloalveolar carcinoma; adenocarcinoma; lung;
D O I
10.1039/U4WGE9EBFJN6CM8R
中图分类号
R36 [病理学];
学科分类号
100104 [病理学与病理生理学];
摘要
We examined the expression of MUC1, MUC2, MUC5AC, and MUC6 by immunohistochemical staining in atypical adenomatous hyperplasia (AAH), bronchioloalveolar carcinoma (BAC), and adenocarcinoma with mixed subtypes (MX) to study the association between the biologic features of adenocarcinoma of the lung and mucin expression. MUC1 expression was decreased significantly in the progression from AAH through BAC to MX, while the levels of expression of MUC2, MUC5AC, MUC6, and depolarized MUC1 were increased significantly. Alterations in the expression of depolarized MUC1, MUC5AC, and MUC6 were correlated significantly with p53 gene abnormalities. Depolarized MUC1 expression also was correlated significantly with Ki-67 expression, and down-regulation of MUC1 expression and up-regulation of MUC6 expression were correlated significantly with tumor size. Our results suggest that the expression of these mucins might be associated with the progression of adenocarcinoma of the lung.
引用
收藏
页码:644 / 653
页数:10
相关论文
共 34 条
[1]
Significance of MUC1 and MUC2 mucin expression in colorectal cancer [J].
Ajioka, Y ;
Allison, LJ ;
Jass, JR .
JOURNAL OF CLINICAL PATHOLOGY, 1996, 49 (07) :560-564
[2]
Comparative evaluation of the prognostic value of MUC1, MUC2, sialyl-Lewisa and sialyl-Lewisx antigens in colorectal adenocarcinoma [J].
Baldus, SE ;
Mönig, SP ;
Hanisch, FG ;
Zirbes, TK ;
Flucke, U ;
Oelert, S ;
Zilkens, G ;
Madejczik, B ;
Thiele, J ;
Schneider, PM ;
Hölscher, AH ;
Dienes, HP .
HISTOPATHOLOGY, 2002, 40 (05) :440-449
[3]
BARSKY SH, 1994, CANCER, V15, P1163
[4]
Guddo F, 1998, ANTICANCER RES, V18, P1915
[5]
MUC1 (episialin) expression in non-small cell lung cancer is independent of EGFR and c-erbB-2 expression and correlates with poor survival in node positive patients [J].
Guddo, F ;
Giatromanolaki, A ;
Koukourakis, MI ;
Reina, C ;
Vignola, AM ;
Chlouverakis, G ;
Hilkens, J ;
Gatter, KC ;
Harris, AL ;
Bonsignore, G .
JOURNAL OF CLINICAL PATHOLOGY, 1998, 51 (09) :667-671
[6]
Hanski C, 1997, LAB INVEST, V77, P685
[7]
Hayashi H, 2000, J PATHOL, V192, P26
[8]
Coexpression of MUC1 with p53 or MUC2 correlates with lymph node metastasis in colorectal carcinomasd [J].
Jang, KT ;
Chae, SW ;
Sohn, JH ;
Park, HR ;
Shin, HS .
JOURNAL OF KOREAN MEDICAL SCIENCE, 2002, 17 (01) :29-33
[9]
Jarrard JA, 1998, CANCER RES, V58, P5582
[10]
Muc4/sialomucin complex, the intramembrane ErbB2 ligand, induces specific phosphorylation of ErbB2 and enhances expression of p27kip, but does not activate mitogen-activated kinase or protein kinase B/Akt pathways [J].
Jepson, S ;
Komatsu, M ;
Haq, B ;
Arango, ME ;
Huang, DM ;
Carraway, CAC ;
Carraway, KL .
ONCOGENE, 2002, 21 (49) :7524-7532